Paul G Thomas Selected Research

deoxythymidine 3',5'-bis-(p-nitrophenyl phosphate)

10/2015	Paired TCRαβ analysis of virus-specific CD8(+) T cells exposes diversity in a previously defined 'narrow' repertoire.
1/2013	Ecological analysis of antigen-specific CTL repertoires defines the relationship between naive and immune T-cell populations.
12/2010	Influenza epitope-specific CD8+ T cell avidity, but not cytokine polyfunctionality, can be determined by TCRβ clonotype.
8/2008	Terminal deoxynucleotidyltransferase is required for the establishment of private virus-specific CD8+ TCR repertoires and facilitates optimal CTL responses.
3/2007	Hidden epitopes emerge in secondary influenza virus-specific CD8+ T cell responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul G Thomas Research Topics

Disease

64	Infections 12/2022 - 04/2005
44	Human Influenza (Influenza) 01/2022 - 01/2006
20	Neoplasms (Cancer) 10/2022 - 12/2010
12	COVID-19 12/2022 - 05/2020
10	Inflammation (Inflammations) 01/2022 - 07/2013
10	Virus Diseases (Viral Diseases) 11/2021 - 05/2013
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 01/2019
5	Pneumonia (Pneumonitis) 12/2019 - 09/2014
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2017
3	Cytokine Release Syndrome 12/2020 - 01/2017
2	Breakthrough Infections 01/2022 - 01/2022
2	Melanoma (Melanoma, Malignant) 01/2022 - 10/2016
2	Residual Neoplasm 01/2021 - 01/2019
2	Leukemia 01/2020 - 01/2015
2	Persistent Infection 12/2018 - 06/2017
2	Communicable Diseases (Infectious Diseases) 12/2018 - 01/2016
2	Lung Injury 01/2018 - 01/2016
2	Coinfection 01/2017 - 03/2014
2	Respiratory Syncytial Virus Infections 12/2011 - 02/2011
1	Breast Neoplasms (Breast Cancer) 10/2022
1	Lung Diseases (Lung Disease) 10/2022
1	Reinfection 01/2022
1	Hepatitis B 01/2022
1	Carcinogenesis 01/2022
1	Neuroblastoma 11/2021
1	Convalescence 11/2021
1	Vesicular Stomatitis 10/2021
1	Berylliosis 01/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 11/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2020
1	Respiratory Insufficiency (Respiratory Failure) 05/2020

Drug/Important Bio-Agent (IBA)

20	EpitopesIBA 01/2022 - 03/2007
19	AntigensIBA 10/2022 - 02/2009
18	CytokinesIBA 01/2022 - 03/2007
17	VaccinesIBA 10/2022 - 04/2005
11	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2013
10	Proteins (Proteins, Gene)FDA Link 05/2020 - 01/2006
9	AntibodiesIBA 12/2022 - 01/2014
8	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 02/2011
7	Peptides (Polypeptides)IBA 11/2021 - 01/2006
6	ChemokinesIBA 01/2022 - 03/2009
5	ImmunosorbentsIBA 05/2022 - 01/2014
5	EnzymesIBA 05/2022 - 01/2014
5	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2014
5	deoxythymidine 3',5'-bis-(p-nitrophenyl phosphate)IBA 10/2015 - 03/2007
4	Biomarkers (Surrogate Marker)IBA 11/2021 - 07/2013
4	InterferonsIBA 12/2020 - 04/2006
4	Interleukin-6 (Interleukin 6)IBA 12/2020 - 01/2016
3	Immunoglobulin A (IgA)IBA 05/2022 - 01/2014
3	Messenger RNA (mRNA)IBA 05/2022 - 09/2021
3	Immunoglobulin G (IgG)IBA 05/2022 - 01/2021
3	Immune Checkpoint InhibitorsIBA 01/2022 - 12/2016
3	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022 - 12/2010
3	Amino Acids FDA Link 11/2021 - 01/2013
3	HLA Antigens (Human Leukocyte Antigens)IBA 11/2021 - 12/2020
3	Oseltamivir (Tamiflu)FDA Link 12/2019 - 01/2015
3	Histones (Histone)IBA 12/2019 - 11/2014
2	Indicators and Reagents (Reagents)IBA 12/2022 - 07/2008
2	Neoplasm Antigens (Tumor Antigens)IBA 10/2022 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2020
2	mRNA VaccinesIBA 01/2022 - 01/2022
2	Monoclonal AntibodiesIBA 09/2021 - 07/2008
2	Viral AntigensIBA 01/2021 - 11/2014
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2020 - 05/2020
2	Peptide Hydrolases (Proteases)FDA Link 11/2020 - 02/2014
2	Histocompatibility Antigens Class IIBA 10/2020 - 12/2010
2	Interferon-gamma (Interferon, gamma)IBA 05/2020 - 12/2014
2	NucleoproteinsIBA 01/2019 - 01/2013
2	AcidsIBA 01/2019 - 01/2013
2	Phospholipase DIBA 05/2017 - 09/2014
2	LipidsIBA 05/2017 - 07/2013
2	Pharmaceutical PreparationsIBA 01/2015 - 12/2013
2	1-dodecylpyridoxal (PLD)IBA 12/2014 - 09/2014
2	Phosphotransferases (Kinase)IBA 12/2013 - 05/2013
1	Chimeric Antigen ReceptorsIBA 11/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	CBLC137IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	RNA Splicing FactorsIBA 11/2021
1	N- (3- chloro- 7- indolyl)- 1,4- benzenedisulphonamide (E7070)IBA 11/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2021
1	RNA Precursors (Precursor, mRNA)IBA 11/2021
1	Arginine (L-Arginine)FDA Link 10/2021
1	2-mercaptopurineIBA 01/2021
1	blinatumomabIBA 01/2021
1	BerylliumIBA 01/2021
1	NucleosidesIBA 01/2021
1	HLA-DR Antigens (HLA-DR)IBA 12/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2020
1	GlucocorticoidsIBA 05/2020
1	SqualeneIBA 01/2020
1	Interleukin-12 Subunit p40IBA 01/2020
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2020

Therapy/Procedure

12	Therapeutics 10/2022 - 03/2014
8	Immunotherapy 01/2020 - 01/2016
3	Drug Therapy (Chemotherapy) 01/2022 - 10/2016
1	Heterologous Transplantation (Xenotransplantation) 01/2020
1	Contraindications 01/2020